Mounjaro 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1S17
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,132
Award facts
- Contract value 100% obligated
- $14,131.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,131.67 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 ml pen injections on December 30, 2025, with performance completion targeted for December 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Mounjaro is a diabetes medication commonly used for glycemic control in military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency and serves critical pharmaceutical distribution needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contracting history demonstrates consistent capability in fulfilling competitively awarded delivery orders across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies at varying transaction values.
Quick answers
Who was awarded contract SPE2DR26F1S17?
SPE2DR26F1S17 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F1S17 worth?
The government has obligated $14,132 on SPE2DR26F1S17.
Is contract SPE2DR26F1S17 an order under another contract?
Yes. SPE2DR26F1S17 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1S17 competed?
The extent of competition for SPE2DR26F1S17 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award